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Abstract
Background: Little is known about the changes in autonomic function during spinal anaesthesia in type 2 diabetic
patients. The purpose of the study was to assess the influence of spinal anaesthesia on the heart rate variability in
type 2 diabetic patients according to the glycated hemoglobin (HbA1c) level.
Methods: Sixty-six patients who were scheduled for elective orthostatic lower limb surgery were assigned to three
groups (n = 22, each) according to HbA1c; controlled diabetes mellitus (HbA1c < 7 %), uncontrolled diabetes mellitus
(HbA1c > 7 %) and the control group. The heart rate variability was measured 10 min before (T0), and at10 min (T1),
20 min (T2) and 30 min (T3) after spinal anaesthesia.
Results: Before spinal anaesthesia, total, low-and high-frequency power were significantly lower in the uncontrolled
diabetec group than in other group (p < 0.05). During spinal anaesthesia, total, low- and high-frequency powers
were did not change in the uncontrolled diabetec group while the low-frequency power in the controlled diabetec
group was significantly depressed (p < 0.05). The ratio of low-to high-frequency was comparable among the
groups, while it was reduced at T1-2 than at T0 in all the groups. The blood pressures were higher in the
uncontrolled diabetec group than in the other groups.
Conclusions: Spinal anaesthesia had an influence on the cardiac autonomic modulation in controlled diabetec
patients, but not in uncontrolled diabetec patients. There were no differences in all haemodynamic variables during
an adequate level of spinal anaesthesia in controlled and uncontrolled type 2 DM.
Trial registration: ClinicalTrials.gov NCT02137057
Keywords: Spinal anaesthesia, Heart rate variability, diabetes mellitus
Background
Type 2 diabetes mellitus (DM) is a widespread disease and
increases the risk of cardiovascular disease [1], peri-
operative hypotension [2, 3] and intra-operative morbidity
[4]. Hyperglycemia in type 2 diabetes is associated with mi-
cro- and macro-complications [5] and causes autonomic
nervous dysfunction. Severe autonomic failure due to sym-
pathetic and parasympathetic dysfunction typically occurs
in patients with long-standing and poorly controlled dia-
betes [6]. The incidence of caused by uncompensated
vasoconstriction during general anaesthesia was highly re-
ported in patients with autonomic nervous dysfunction due
to diabetes [2]. Therefore, these patients present a major
challenge to the anaesthetist. Strict glycemic control can
decrease the morbidity rate for various complications of
type 2 diabetes, thus the glycated hemoglobin (HbA1c) level
is recommended below 7 % [7].
Heart rate variability (HRV) is a standard screening
parameter for diagnosis of autonomic dysfunction [8, 9].
The total power reflects the overall autonomic modula-
tion [10, 11] and is considered an estimation of the bal-
ance between sympathetic and parasympathetic nerve
activities. Several studies have reported linear or non-
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linear correlations between chronic hyperglycemia and
HRV [12–15].
The blockade of pre-ganglionic sympathetic fibres and
cardiac sympathetic innervation during spinal anaesthe-
sia can induce central sympatholysis. Therefore, the ef-
fects of sympathetic blockade on cardiac autonomic
nervous function in type 2 diabetes are expected to be
different from that in normal patients.
Previous studies have reported that hypotension during
spinal anaesthesia can be predicted by changes in the ratio
of low to high frequency power [16, 17], although the sub-
jects in their studies were not DM patients and the blood
pressure (BP) changes according to HbA1c levels were not
verified during spinal anaesthesia.
Little is known about changes in cardiac autonomic ner-
vous function during spinal anaesthesia in type 2 diabetes.
In addition, there was not enough evidence whether
bradycardia and hypotension occur more frequently with
uncontrolled diabetes patients than controlled diabetes or
normal patients during spinal anaesthesia. In type 2 dia-
betes patients, although the specific mechanisms have not
been established, it is clear that sympathetic blockage
caused by spinal anaesthesia has effects on the cardiac
autonomic system. The primary outcome of our study was
to evaluate the change of cardiac autonomic system in
spinal anaesthesia using the component of HRV in type 2
diabetes patients comparing with non-diabetic patients.
Methods
This study received approval from the institutional re-
view board of Severance Hospital, Yonsei University
Health System, Seoul, South Korea (Ref. 4-2014-0167)
on April 29, 2014 and was registered at ClinicalTrials.gov
(NCT 02137057). This prospective observational study
followed the STROBE guideline (Additional file 1). A
total of 66 adult patients aged 40–80 years with an
American Society of Anaesthesiologists physical status
of I–III who were scheduled to undergo elective lower
limb orthostatic surgery were enrolled after obtaining
informed written consent. The exclusion criteria com-
prised contraindication to spinal anaesthesia, patients
with arrhythmia and those taking medications that
affect the autonomic nervous system, such as anti-
depressants, hypnotics, β- and α-adrenergic blockers.
Patient’s allocation
Patients were allocated into their respective groups by set-
ting HbA1c 7 % as our parameter for patients previously di-
agnosed with DM in the following matter: controlled DM
(HbA1c < 7 %), uncontrolled DM (HbA1c > 7 %) and nor-
mal groups (n = 22, each). Normal patients were defined as
never having a previous diagnosis of DM and a fasting ran-
domized sugar level < 200 and thereby not fitting the cri-
teria for impaired glucose tolerance.
Anaesthetic management
No patient was pre-medicated. All patients were moni-
tored using electrocardiography, non-invasive BP mea-
surements and pulse oximetry from arrival in the
operating room. For HRV analysis, PowerLab (AD
Instruments, Sydney, NSW, Australia) was used to auto-
matically save cardiac electrophysiology measurements.
The day before surgery, it is standard to start fasting at
midnight and dehydration that comes with this is sup-
plemented with NS 5 ml/kg before spinal anaesthesia.
This is the standard care at our hospital.
All patients were stabilized for 20 min. For spinal an-
aesthesia, a 22 G spinal needle aimed at the lumber
(L)3–4 or L4-5 inter-vertebral space was used, and with
the patients in a lateral position, 10–12 mg of 0.5 %
hyperbaric bupivacaine was injected into the subarach-
noid space. After spinal injection, a infusion of 6 %
hydroxyethyl starch (Voluven®; Fresenius Kabi, Bad
Homburg, Germany) was started at a rate of 5 ml/kg.
The level of spinal block was confirmed by the loss of
pain sensation after a pin-prick test, with the target level
being T6–8. Baseline blood pressure and pulse rate were
recorded in the supine position 10 min before and at 10,
20 and 30 min after spinal anaesthesia. Hypotension was
defined as a systolic blood pressure < 90 mmHg, and was
managed by 4 mg of ephedrine gradually injected until
normalization of systolic blood pressure. Bradycardia
was defined as a heart rate (HR) of < 50 beats.min−1
based on a consecutive recording of ≥15 sec, and was
managed by administering 0.25–0.5 mg of atropine.
HRV analysis
HRV analysis was conducted using LabChart v7 software
(AD Instruments, Sydney, NSW, Australia) according to
the Task Force of the European Society of Cardiology
and the North American Society of Pacing and Electro-
physiology recommendations [10]. During the recording,
using a sampling rate of 1000H as a threshold method,
we evaluated the fast peak R wave of ECG. A computer
was used to record and analysis the beat to beat variabil-
ity of consecutive R wave of sinus rhythm. Abnormal RR
interval of premature beat of artifact that included noise
was automatically removed by LabChart. The low-
frequency (LF, 0.04–0.15Hz) component of HRV is me-
diated by both sympathetic and parasympathetic nerve
activities, while the high-frequency (HF, 0.15–0.4 Hz)
component is mediated almost entirely by parasympa-
thetic nerve activity. The total power (TP, 0–0.4 Hz)
reflects the overall autonomic activity [10, 11] and LF/
HF ratio verifies the balance between sympathetic and
parasympathetic nerve activities. Frequency-domain ana-
lysis of HRV was conducted using data from 5 min
segments without ectopic beats and artefacts using fast-
Fourier transformation. Time points were set at 10 min
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before (T0), 10 (T1), 20 (T2) and 30 min (T3) after
spinal anaesthesia.
Statistical analysis
Data from a previous study gave a mean (SD) of 630
(190) ms2 of TP in DM patients [18]. We estimated
that 20 patients in each group would be required to
detect a mean difference of 120 ms2 and standard de-
viation 190 ms2 in the TP between DM groups and
normal group with a power of 80 % at a significance of
P < 0.05. To compensate for possible dropouts, we in-
cluded 22 patients per group. All variable data were
tested for normality using the Kolmogorov-Smirnov
test. For inter-groups comparisons, one-way ANOVA
with Bonferroni correction, chi-square or Fisher’s
exact test were used. For intra-group comparisons of
HRV and haemodynamic parameters compared to
each baseline values, repeated measures analysis of
variance with Bonferroni corrections was used. Statistical
analyses were performed using SPSS 20.0 software (SPSS
Inc., Chicago, IL, USA) and a p value of < 0.05 was consid-
ered statistically significant.
Results
Seventy nine patients were determined to be eligible for
this study, but 5 of them were excluded due to decline
to participate this study and 8 were not studied due to
history of arrhythmia or those taking medications that
affect the autonomic nervous system (Figure 1). There
were no differences of the patients’ age, body mass index
and sex (Table 1). The median peak block level was T 6
± 2 with no difference among the three groups. The
HbA1c level was 8.5 ± 1.0 % in uncontrolled DM and
6.5 ± 0.4 % in controlled DM. The incidence of
hypotension and bradycardia was not different among
the groups. In addition, the given number of ephedrine
was not differentiated between the groups (Table 1).
Changes in heart rate variability
The total, LF and HF powers were lower in the uncon-
trolled DM than in the other groups at T0 (p < 0.05).
The total power of controlled DM was significantly
lower than that of the normal group and significantly
higher than that of the uncontrolled group at T0-1. The
LF power in the controlled DM group decreased
Table 1 Characteristics of patients
Normal group (n = 22) Controlled DM (n = 22) Uncontrolled DM (n = 22)
Age (years) 58.7 ± 9.7 64.9 ± 7.5 62.2 ± 10.3
Male/female 9/13 10/12 8/14
Height (cm) 160.8 ± 8.1 161.1 ± 8.5 163.0 ± 10.8
Weight (kg) 65.1 ± 9.5 66.4 ± 10.6 66.1 ± 13.8
BMI (kg/m2) 25.2 ± 4.1 25.4 ± 10.6 24.7 ± 4.0
DM duration (years) NA 7.3 ± 5.8* 15.8 ± 8.1*
HbA1c (%) 5.2 ± 0.4 6.5 ± 0.4* 8.5 ± 1.0*
ASA classification 1/2/3 12/8/2 9/10/3 0/14/8
DM medication
Oral hypoglycemics NA 11 7
Insulin NA 7 7
Combined (oral + insulin) NA 4 8
Blocked sensory T level 6 ± 2 6 ± 2 6 ± 2
Type of operation (n)
Amputation (toe or knee) 0 2 7
Open reduction of fracture 10 3 5
Arthroscopic surgery 3 5 0
Debridement and curettage 2 4 5
Removal of fixation device 7 5 1
Bipolar hemiarthroplasty 0 3 4
Ephedrine given (n) 2 2 2
Hypertension (n) 2 (9 %) 4 (18 %) 2 (9 %)
CAN NA 1 (4 %) 4 (18 %)*
Values are expressed as mean ± SD or number (proportion). DM, type 2 diabetes mellitus; BMI, body mass index; HbA1c, glycated hemoglobin; T, thoracic level;
CAN, cardiac autonomic neuropathy
*P < 0.05 compared to normal group
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significantly and was lower than that of the normal
group at T1–2. The LF power was not changed but sig-
nificantly lower in uncontrolled DM group than in the
normal group at T1–3. The HF power was significantly
higher than that in the uncontrolled DM at T1-T3.
There were no differences in the LF/HF ratio among the
three groups, with the LF/HF ratio reduced at T1-2 than
at T0 in all groups (Table 2; Fig. 2).
Changes in haemodynamic
The systolic, mean and diastolic BP showed no differ-
ences among the three groups at T0. The systolic, mean
and diastolic BP at T1-3 were reduced than that at T0 in
all groups. The systolic, mean and diastolic BP of uncon-
trolled DM group at T1-3 were higher than in the other
groups. However there were no differences in HR at T0-
3 among the three groups. The HR was reduced at T3
than at T0 in the normal group and reduced at T2 and
T3 than at T0 in controlled and uncontrolled DM group.
The pulse pressure for uncontrolled DM was highest
among the groups, but was not statistically different at
T0; it remained significantly higher in uncontrolled DM
compared with the other groups at T1–3 (Table 3).
There were no differences in all haemodynamic variables
between the controlled DM and normal groups.
Discussion
Our study provides a description of autonomic nervous
system modulation on cardiac activity among diabetic
patients undergoing spinal anaesthesia. The original
findings of this study are that patients with uncontrolled
DM have a lower baseline total, LF and HF power than
the controlled DM and normal groups. We expected
that in DM patients, who have affected autonomic nerve
systems, spinal anaesthesia would have a greater effect
on the autonomic function. However, as seen in our re-
sults, after spinal anaesthesia, the LF/HF ratio, which
represents the balance of the autonomic system, was
well maintained. Compared to the uncontrolled DM
group, the controlled DM group had more a similar LF/
HF ratio change to the normal patient group. In
addition, the uncontrolled DM group, which have a de-
creased power of HRV component, as the LF/HF ratio
was recovered, the autonomic nerve modulation was
preserved. Haemodynamic stability was well maintained
during spinal anaesthesia in controlled and uncontrolled
DM groups.
The total power reflects the overall autonomic activity
[10, 19]. Singh et al. stated the more severe the hypergly-
cemia, the more the total power decreases [13]. The cor-
relations of the degree of hyperglycaemia with total, LF
and HF power have been reported [12–15, 20]. In our
study, the total, we were depressed in type 2 DM with
uncontrolled hyperglycemia. Chronic hyperglycemia af-
fects vascular dynamics along with oxidative stress and
plays a key role in the pathogenesis of autonomic cardiac
neuropathy [21, 22] and arterial stiffness [23, 24]. In this
study, differences of total, LF and HF power during
spinal anaesthesia were definite between controlled and
uncontrolled DM, which were based on a standard
HbA1c level of 7 %. We found an association between
high HbA1c level and low power of HRV component
during spinal anaesthesia. Consistent with the findings
of previous studies [2, 25], the LF/HF ratio showed no
significant differences among the three groups. Similar
to our results, Istenes et al. could not find statistical
Table 2 Changes of heart rate variability
Group T 0 T1 T2 T3
Total power (ms2) Normal group 740.0 ± 235.5 587.3 ± 171.7* 495.1 ± 189.7* 511.2 ± 123.9*
Controlled DM 487.5 ± 188.4† 458.8 ± 200.2† 410.9 ± 157.9 396.1 ± 163.4
Uncontrolled DM 328.9 ± 105.0†,‡ 338.5 ± 100.3†,‡ 344.0 ± 88.5† 339.6 ± 84.4†
LF power (ms2) Normal group 326.4 ± 219.0 247.2 ± 190.5 292.6 ± 217.2 294.2 ± 230.0
Controlled DM 296.2 ± 182.4 150.8 ± 64.5*,† 155.6 ± 131.0*,† 240.2 ± 194.2
Uncontrolled DM 163.8 ± 115.3†,‡ 121.4 ± 83.8† 133.8 ± 117.3† 126.5 ± 108.0†
HF power (ms2) Normal group 113.2 ± 77.5 177.5 ± 133.1 198.0 ± 177.5 193.9 ± 130.2
Controlled DM 124.5 ± 104.3 140.9 ± 88.4 162.7 ± 194.3 163.4 ± 157.6
Uncontrolled DM 59.8 ± 49.8†,‡ 61.5 ± 54.0†,‡ 66.6 ± 39.3†,‡ 57.5 ± 48.1†,‡
LF/HF ratio Normal group 3.3 ± 1.2 1.8 ± 1.2* 1.7 ± 0.9* 2.1 ± 1.8
Controlled DM 3.0 ± 1.8 1.7 ± 1.5* 1.6 ± 1.5* 2.2 ± 1.7
Uncontrolled DM 3.3 ± 2.2 1.9 ± 0.9* 1.7 ± 0.8* 2.4 ± 1.3
Values are expressed as mean ± SD. DM, type 2 diabetes mellitus; LF, low-frequency power; HF, high-frequency power; T0, 10 min before spinal anaesthesia; T1,
10 min; T2, 20 min; T3, 30 min after spinal anaeshthesia
*P < 0.05 compared to T0
†P < 0.05 compared to normal group
‡P < 0.05 compared to controlled DM group
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significance between LF/HF ratio with type 2 DM [25].
We performed thoracic spinal anaesthesia (median sen-
sory block; range, T6–8) in this study, although a sympa-
thetic block can extend above the 2–6 dermatome
compared with sensory loss [26]. Therefore, the sympa-
thetic block can be at 2–6 dermatomes higher than the
checked blocked sensory level. Also, as the autonomic
nervous system is maintained by a balance of the sympa-
thetic and parasympathetic system, the increase of HF
can not be soley credited to rise of vagal tone as we
must consider the suppression or inhibition of the sym-
pathetic modulation as a factor. A decrease in the LF/
HF ratio and BP at 10 min after spinal anaesthesia
seemed to occur in all three groups because the cardiac
sympathetic tone of the myocardium was weakly blocked
during spinal anaesthesia. We concluded that the auto-
nomic nervous modulation was already markedly de-
creased and that spinal anaesthesia itself did not affect
autonomic nervous function in the uncontrolled DM
group, thus the cardiac autonomic modulation, which
typically associated with spinal anaesthesia, did not
occur. This suggests that cardiac autonomic nervous
regulation is reduced in patients with uncontrolled DM
during spinal anaesthesia without any significant change
in the sympatho-vagal balance. In contrast, we con-
firmed that spinal anaesthesia significantly affected the
autonomic nervous modulation in the controlled DM
and normal groups. The systolic and mean BP after
spinal anaesthesia was significantly higher in uncon-
trolled DM than in the other groups, indicating that
sympatho-vagal function disturbance is not exacerbated
under the adequate spinal block in the uncontrolled DM
and the incidence of was comparable with controlled
DM and normal group. We also observed an elevated
pulse pressure in the patients with uncontrolled DM,
which may reflect arterial stiffness. Various studies re-
ported that a high systolic blood pressure in DM can be
attributed to the effects of hyperglycaemia on the vascu-
lar endothelium and peripheral nerves through its inter-
action with vascular and metabolic factors [21, 22].
Fig. 1 Study process of showing this trial
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Arterial stiffness and thickness caused by vascular dys-
function in type 2 DM are correlated with an increase in
systolic BP [23, 27]. Furthermore, four patients in uncon-
trolled DM were diagnosed with cardiac autonomic neur-
opathy [28] in our study. Therefore, the high systolic BP
and pulse pressure both reflect arterial stiffness secondary
to neuropathy and associated vascular damage.
DM patients with cardiac autonomic neuropathy who
received general anaesthesia experienced a more pro-
found decrease in HR and BP and an increased use of
Fig. 2 Heart rate variability measurement (a) total power (b) low-frequency (LF) power (c) high-frequency (HF) power (d) LF/HF ratio. Data are
mean with error bars showing SD. T0, 10 min before spinal anaesthesia; T1, 10 min; T2, 20 min; T3, 30 min after spinal anaeshthesia; normal group
N (●),controlled DM group (□), uncontrolled DM group (○). *P < 0.05 compared to T0; †P < 0.05 compared to normal group; ‡P < 0.05 compared to
controlled DM group
Table 3 Changes in haemodynamics
Group T 0 T1 T2 T3
Heart rate Normal group 70.5 ± 11.9 70.5 ± 13.7 65.5 ± 15.8 62.3 ± 14.6*
(Beats per minute) Controlled DM 73.7 ± 12.8 73.5 ± 16.0 67.4 ± 16.1* 65.9 ± 15.4*
Uncontrolled DM 77.5 ± 12.3 74.7 ± 13.6 72.8 ± 12.8* 71.6 ± 13.0*
Systolic blood pressure Normal group 144.1 ± 16.3 122.4 ± 14.0* 118.9 ± 14.2* 119.0 ± 14.4*
(mmHg) Controlled DM 144.5 ± 20.2 119.2 ± 19.3* 118.6 ± 18.6* 118.3 ± 19.9*
Uncontrolled DM 152.9 ± 19.4 134.6 ± 22.1*,†.‡ 134.6 ± 25.0*,†.‡ 137.2 ± 20.2*,†.‡
Mean blood pressure Normal group 111.1 ± 13.0 94.9 ± 12.5* 92.1 ± 10.8* 91.8 ± 11.3*
(mmHg) Controlled DM 110.5 ± 15.1 89.8 ± 14.1* 91.6 ± 14.3* 90.9 ± 14.7*
Uncontrolled DM 113.5 ± 14.3 103.6 ± 17.6*,‡ 102.7 ± 18.1*,‡ 105.1 ± 16.5*,‡
Diastolic blood pressure Normal group 83.5 ± 11.0 73.5 ± 9.3* 71.2 ± 8.9* 71.2 ± 9.8*
(mmHg) Controlled DM 84.4 ± 9.1 71.0 ± 10.9* 72.3 ± 12.4* 70.9 ± 11.7*
Uncontrolled DM 84.4 ± 12.0 78.9 ± 15.4*,†.‡ 78.6 ± 14.2*,†.‡ 79.4 ± 14.2*,†.‡
Pulse pressure Normal group 59.9 ± 11.9 47.7 ± 8.1 47.1 ± 11.8 46.9 ± 11.1
(mmHg) Controlled DM 60.1 ± 17.1 48.1 ± 11.6 46.3 ± 11.3 47.4 ± 12.1
Uncontrolled DM 68.5 ± 16.4 58.7 ± 16.4†,‡ 59.0 ± 16.4†,‡ 57.8 ± 16.1†,‡
Values are expressed as mean ± SD. DM, type 2 diabetes mellitus; LF, low-frequency power; HF, high-frequency power; T0, 10 min before spinal anaesthesia; T1,
10 min; T2, 20 min; T3, 30 min after spinal anaeshthesia
*P < 0.05 compared to T0
†P < 0.05 compared to normal group
‡P < 0.05 compared to controlled DM group
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vasoactive drugs during induction [2]. This probably oc-
curred due to the lack of compensatory mechanisms for
the vasodilatory effect against systemically administered
anaesthetics. Cardiac autonomic neuropathy is induced
by several processes, including metabolic insult to nerve
fibres, neurovascular insufficiency and the formation of
advanced glycated end products [28]. Cardiac autonomic
neuropathy involves the sympathetic and parasympa-
thetic nervous systems depending on disease progres-
sion. As a result, HR remains constant, the coronary
vasodilatory reserve is impaired, the micro-circulation
decreases, and diastolic dysfunction occurs [29]. There-
fore, the administration of an adequate level of spinal
anaesthesia instead of general anaesthesia to patients
with diabetic cardiomyopathy who exhibit normal sys-
tolic function and impaired diastolic function [30] might
lead to and the ratio of low to high frequency a lesser
impact on sympatho-vagal balance.
In addition to the above factors, this study has several
limitations. First, patients were divided according to
HbA1c levels, not to the presence of cardiac autonomic
neuropathy. The prevalence of cardiac autonomic neur-
opathy in type 2 DM patients is 34 % [28], and it be-
comes more evident 18 months after DM diagnosis [31].
We focused the changes in autonomic nervous function
targeting HbA1c, because diagnosis for cardiac auto-
nomic neuropathy was not performed in all DM patients
and HbA1c is used as a standard for treatment [7]. Sec-
ond, patients who were taking β-blockers, angiotensin
receptor blockers or angiotensin-converting enzyme in-
hibitors [32, 33], which can affect the autonomic ner-
vous system, were excluded from this study; however,
HRV depression by hypertension itself, including the LF
and HF components, may have influenced our results
[34]. Furthermore, DM patients are subjected to concur-
rent multiple drug use, therefore the combined effect of
various drugs on the autonomic nervous system could
inflict on our result. Third, systemic vascular resistance
was not verified and vascular stiffness was not measured.
Because DM patients with cardiac autonomic neur-
opathy exhibit central and peripheral vascular dysfunc-
tion [32], a decrease in systemic vascular resistance due
to sympathetic block by spinal anaesthesia could be
more severe [35]. Fourth, we analyzed sequences of
5 min. Our study examined the changes of HRV for a
short duration of time of 30 minutes before and after
spinal anaesthesia. Since the heart rate (R-to-R intervals)
was different among studied patients, differences in
length of tachograms can influence the derived power
spectra patterns. Thereby, short sequences can under-
estimate LF component and overestimate the rapid fluc-
tuations (HF component).
There are several confounding factors regarding HRV in
our study. The HF power decreases in elderly patients,
and the LF/HF ratio shows a positive correlation with age
[36, 37]. Moreover, females show a decreased LF/HF ratio
compared with males [20, 37]. Because our study aimed to
verify changes in autonomic function during SA in DM
patients, HRV could only be analysed during surgery.
Surgery-related anxiety or emotional stress may also affect
HRV [38]. Because HRV is affected by PaCO2, the breath-
ing pattern may have influenced our results [39]. The cen-
tral frequency of the HF band of the heart rate coincides
with the central frequency of the respiratory rate. If the re-
spiratory rate is low (for example 10 breaths per min, cor-
responding to a frequency of 0.17 Hz, very near to the
upper limit of LF), some amount of HF band overlaps with
the LF band, thus the exact estimation of both bands be-
comes difficult. We need to consider the fact that DM pa-
tients with CAN lack HRV during deep breathing [29]. The
HF power is mainly driven by respiration, and this causes
vagal-mediated respiratory sinus arrhythmia [33]. The mag-
nitude of the HF power is largely influenced by the depth
of respiration, and this must be considered during SA.
Conclusions
Our findings suggest that spinal anaesthesia had an influ-
ence on the cardiac autonomic modulation in controlled
DM patients. Cardiac autonomic modulation did not
change during spinal anaesthesia for lower limb surgery in
uncontrolled DM patients who had a lower baseline auto-
nomic nervous system modulation. However, there was
no severe caused by a disturbance of sympatho-vagal
function during the adequate spinal anaesthesia in con-
trolled and uncontrolled type 2 DM.
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